| microtubule polymerization or depolymerization | GO:0031109 | 26 | 0.524 | |
| organelle assembly | GO:0070925 | 177 | 0.446 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.338 | |
| organelle localization | GO:0051640 | 179 | 0.318 | |
| dna metabolic process | GO:0006259 | 303 | 0.314 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.273 | |
| microtubule based process | GO:0007017 | 236 | 0.257 | |
| cell fate commitment | GO:0045165 | 210 | 0.224 | |
| nuclear division | GO:0000280 | 158 | 0.218 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.197 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.188 | |
| protein depolymerization | GO:0051261 | 34 | 0.185 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.179 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.166 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.153 | |
| cytokine production | GO:0001816 | 319 | 0.151 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.147 | |
| cell division | GO:0051301 | 120 | 0.144 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.141 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.139 | Worm |
| regulation of nuclear division | GO:0051783 | 56 | 0.136 | |
| chromosome segregation | GO:0007059 | 48 | 0.134 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.134 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.132 | |
| spindle assembly involved in meiosis | GO:0090306 | 4 | 0.131 | |
| lateral inhibition | GO:0046331 | 1 | 0.123 | |
| endomembrane system organization | GO:0010256 | 147 | 0.122 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.120 | |
| organelle fission | GO:0048285 | 170 | 0.120 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.119 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.118 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.117 | |
| negative regulation of microtubule polymerization or depolymerization | GO:0031111 | 15 | 0.110 | |
| regionalization | GO:0003002 | 337 | 0.109 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.108 | |
| spindle assembly involved in female meiosis | GO:0007056 | 3 | 0.108 | |
| positive regulation of exit from mitosis | GO:0031536 | 1 | 0.108 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.106 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.103 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.102 | |
| centrosome cycle | GO:0007098 | 23 | 0.102 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.101 | |
| stem cell development | GO:0048864 | 219 | 0.101 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.101 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.099 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.099 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.098 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.097 | Mouse |
| centrosome duplication | GO:0051298 | 16 | 0.096 | |
| protein processing | GO:0016485 | 163 | 0.096 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.095 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.094 | |
| negative regulation of microtubule depolymerization | GO:0007026 | 13 | 0.093 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.087 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.087 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.087 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.086 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.085 | |
| dendrite development | GO:0016358 | 115 | 0.084 | |
| b cell activation | GO:0042113 | 161 | 0.083 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.083 | |
| stem cell differentiation | GO:0048863 | 268 | 0.080 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.079 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.078 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.076 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.074 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.071 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.071 | |
| immune effector process | GO:0002252 | 321 | 0.071 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.070 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.070 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.068 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.067 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.067 | |
| protein polymerization | GO:0051258 | 57 | 0.066 | |
| stem cell maintenance | GO:0019827 | 130 | 0.065 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.065 | |
| developmental maturation | GO:0021700 | 193 | 0.063 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.063 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.063 | |
| chromatin organization | GO:0006325 | 206 | 0.062 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.062 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.062 | |
| axonogenesis | GO:0007409 | 274 | 0.060 | |
| protein localization to organelle | GO:0033365 | 185 | 0.060 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.060 | |
| regulation of protein localization | GO:0032880 | 231 | 0.060 | |
| chromatin modification | GO:0016568 | 187 | 0.060 | |
| microtubule depolymerization | GO:0007019 | 15 | 0.058 | |
| germ cell development | GO:0007281 | 185 | 0.058 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.058 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.058 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.058 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.057 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.057 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.057 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.056 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.056 | |
| cleavage furrow formation | GO:0036089 | 2 | 0.056 | |
| establishment of spindle localization | GO:0051293 | 19 | 0.056 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.055 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.055 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.054 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.054 | |
| regulation of neuron death | GO:1901214 | 134 | 0.054 | |
| histone modification | GO:0016570 | 159 | 0.053 | |
| spindle localization | GO:0051653 | 22 | 0.052 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.051 | |
| spermatogenesis | GO:0007283 | 284 | 0.051 | |
| centrosome organization | GO:0051297 | 26 | 0.051 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.051 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 36 | 0.050 | |
| microtubule polymerization | GO:0046785 | 12 | 0.050 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.050 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.050 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.049 | |
| cellularization | GO:0007349 | 1 | 0.049 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 37 | 0.049 | |
| maintenance of location | GO:0051235 | 89 | 0.048 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.048 | |
| regulation of cell division | GO:0051302 | 76 | 0.048 | |
| t cell activation | GO:0042110 | 289 | 0.048 | |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 20 | 0.048 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.047 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.047 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.047 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.047 | |
| protein maturation | GO:0051604 | 176 | 0.046 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.046 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.046 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.046 | |
| regulation of mitosis | GO:0007088 | 29 | 0.046 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.046 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.046 | |
| muscle tissue development | GO:0060537 | 308 | 0.046 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.046 | |
| male gamete generation | GO:0048232 | 285 | 0.045 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.045 | |
| spindle assembly | GO:0051225 | 13 | 0.045 | |
| neural tube development | GO:0021915 | 160 | 0.044 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.044 | |
| cell cycle arrest | GO:0007050 | 37 | 0.044 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.044 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.044 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.043 | |
| spindle assembly involved in mitosis | GO:0090307 | 4 | 0.043 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.043 | |
| dna repair | GO:0006281 | 107 | 0.043 | |
| establishment or maintenance of apical basal cell polarity | GO:0035088 | 21 | 0.042 | |
| metencephalon development | GO:0022037 | 89 | 0.042 | |
| protein catabolic process | GO:0030163 | 221 | 0.042 | |
| gland development | GO:0048732 | 330 | 0.042 | |
| camera type eye development | GO:0043010 | 266 | 0.042 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.041 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.041 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.041 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.041 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.040 | |
| positive regulation of chromosome segregation | GO:0051984 | 4 | 0.040 | |
| cell cycle g2 m phase transition | GO:0044839 | 20 | 0.040 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.040 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.040 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.040 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.039 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.039 | |
| placenta development | GO:0001890 | 140 | 0.038 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.038 | |
| metaphase plate congression | GO:0051310 | 2 | 0.038 | |
| cytokinetic process | GO:0032506 | 2 | 0.038 | |
| forebrain development | GO:0030900 | 302 | 0.038 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.038 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.037 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.037 | Mouse |
| positive regulation of cell development | GO:0010720 | 237 | 0.037 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.037 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.037 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.037 | |
| primary neural tube formation | GO:0014020 | 95 | 0.037 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.036 | |
| neuron death | GO:0070997 | 154 | 0.036 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.036 | |
| digestive system development | GO:0055123 | 200 | 0.036 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.036 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.036 | |
| oocyte differentiation | GO:0009994 | 35 | 0.036 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.035 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.035 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.034 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.034 | |
| b cell differentiation | GO:0030183 | 78 | 0.034 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.033 | |
| regulation of mitotic sister chromatid segregation | GO:0033047 | 12 | 0.033 | |
| positive regulation of mitotic cell cycle embryonic | GO:0045977 | 2 | 0.033 | |
| tendon formation | GO:0035992 | 4 | 0.033 | |
| neuron migration | GO:0001764 | 122 | 0.033 | |
| response to cell cycle checkpoint signaling | GO:0072396 | 1 | 0.033 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.033 | |
| positive regulation of mitosis | GO:0045840 | 14 | 0.032 | |
| cell fate specification | GO:0001708 | 72 | 0.032 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.032 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.032 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.032 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.032 | |
| protein ubiquitination | GO:0016567 | 171 | 0.031 | |
| ear development | GO:0043583 | 200 | 0.031 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.031 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.031 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.030 | |
| muscle cell development | GO:0055001 | 133 | 0.030 | |
| rhythmic process | GO:0048511 | 174 | 0.030 | |
| regulation of ubiquitin protein ligase activity involved in mitotic cell cycle | GO:0051439 | 1 | 0.030 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.030 | |
| regulation of secretion | GO:0051046 | 274 | 0.030 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.030 | |
| blood circulation | GO:0008015 | 195 | 0.030 | |
| hair cell differentiation | GO:0035315 | 40 | 0.030 | |
| fertilization | GO:0009566 | 127 | 0.029 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.029 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.029 | |
| positive regulation of nuclear division | GO:0051785 | 27 | 0.029 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.028 | |
| positive regulation of mitotic sister chromatid separation | GO:1901970 | 2 | 0.028 | |
| amine metabolic process | GO:0009308 | 45 | 0.028 | |
| ossification | GO:0001503 | 216 | 0.028 | |
| embryonic placenta development | GO:0001892 | 98 | 0.028 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.028 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.028 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.028 | |
| negative regulation of cell aging | GO:0090344 | 5 | 0.028 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.027 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.027 | |
| stem cell proliferation | GO:0072089 | 117 | 0.027 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.027 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.027 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.027 | |
| digestive tract development | GO:0048565 | 190 | 0.027 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.027 | |
| endocytosis | GO:0006897 | 168 | 0.027 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.027 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.026 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.026 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.026 | |
| regulation of protein transport | GO:0051223 | 163 | 0.026 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.026 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.026 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.026 | |
| synapse organization | GO:0050808 | 125 | 0.026 | |
| membrane organization | GO:0061024 | 245 | 0.026 | |
| circulatory system process | GO:0003013 | 197 | 0.026 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.026 | |
| protein complex disassembly | GO:0043241 | 40 | 0.026 | |
| spindle midzone assembly | GO:0051255 | 1 | 0.025 | |
| ear morphogenesis | GO:0042471 | 118 | 0.025 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.025 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.025 | |
| heart morphogenesis | GO:0003007 | 178 | 0.025 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.025 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.025 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.025 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.025 | |
| nuclear transport | GO:0051169 | 139 | 0.025 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.025 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.025 | |
| microtubule nucleation | GO:0007020 | 2 | 0.024 | |
| dephosphorylation | GO:0016311 | 129 | 0.024 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.024 | |
| mapk cascade | GO:0000165 | 281 | 0.024 | |
| cellular homeostasis | GO:0019725 | 240 | 0.024 | |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.024 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.024 | |
| regulation of protein processing | GO:0070613 | 96 | 0.024 | |
| liver development | GO:0001889 | 66 | 0.024 | |
| skin development | GO:0043588 | 220 | 0.024 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.024 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.024 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.024 | |
| female gamete generation | GO:0007292 | 74 | 0.024 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.024 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.024 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.024 | |
| meiotic spindle organization | GO:0000212 | 9 | 0.024 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.024 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.024 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.023 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.023 | |
| establishment of spindle orientation | GO:0051294 | 15 | 0.023 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.023 | |
| regulation of chromosome segregation | GO:0051983 | 21 | 0.023 | |
| cell maturation | GO:0048469 | 127 | 0.023 | |
| cation transport | GO:0006812 | 399 | 0.023 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.023 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.023 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.023 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.023 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.023 | |
| regulation of protein depolymerization | GO:1901879 | 26 | 0.023 | |
| regulation of microtubule depolymerization | GO:0031114 | 13 | 0.023 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.023 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.023 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.023 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.023 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.022 | |
| adaptive immune response | GO:0002250 | 155 | 0.022 | |
| cell fate determination | GO:0001709 | 32 | 0.022 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.022 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.022 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.022 | |
| dna endoreduplication | GO:0042023 | 4 | 0.022 | |
| telencephalon development | GO:0021537 | 186 | 0.022 | |
| body morphogenesis | GO:0010171 | 45 | 0.022 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.021 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.021 | |
| respiratory system development | GO:0060541 | 190 | 0.021 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.021 | |
| hexose metabolic process | GO:0019318 | 98 | 0.021 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.021 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.021 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.021 | |
| regulation of protein stability | GO:0031647 | 52 | 0.021 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.021 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.021 | |
| membrane disassembly | GO:0030397 | 1 | 0.021 | |
| t cell differentiation | GO:0030217 | 174 | 0.021 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.021 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.021 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.021 | |
| epidermis development | GO:0008544 | 187 | 0.020 | |
| ventricular cardiac muscle cell development | GO:0055015 | 11 | 0.020 | |
| dna conformation change | GO:0071103 | 37 | 0.020 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.020 | |
| sclerotome development | GO:0061056 | 4 | 0.020 | |
| skeletal system development | GO:0001501 | 356 | 0.020 | |
| respiratory tube development | GO:0030323 | 167 | 0.020 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.020 | |
| positive regulation of cell division | GO:0051781 | 31 | 0.020 | |
| microtubule based movement | GO:0007018 | 84 | 0.020 | |
| striated muscle cell development | GO:0055002 | 125 | 0.020 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.020 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.020 | |
| female meiosis i | GO:0007144 | 7 | 0.020 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.020 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.020 | |
| nucleus localization | GO:0051647 | 20 | 0.020 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.020 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.020 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.020 | |
| thymus development | GO:0048538 | 41 | 0.020 | |
| stem cell fate specification | GO:0048866 | 3 | 0.019 | |
| negative regulation of neuron projection regeneration | GO:0070571 | 3 | 0.019 | |
| mitral valve development | GO:0003174 | 4 | 0.019 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.019 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.019 | |
| oogenesis | GO:0048477 | 56 | 0.019 | |
| tube closure | GO:0060606 | 91 | 0.019 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.019 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.019 | |
| positive regulation of mechanoreceptor differentiation | GO:0045633 | 1 | 0.019 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.019 | |
| hindbrain formation | GO:0021576 | 1 | 0.019 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.019 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.019 | |
| pallium development | GO:0021543 | 120 | 0.019 | |
| interleukin 8 production | GO:0032637 | 4 | 0.019 | |
| protein targeting | GO:0006605 | 143 | 0.019 | |
| meiosis i | GO:0007127 | 60 | 0.018 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.018 | |
| neuron fate specification | GO:0048665 | 30 | 0.018 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.018 | Mouse |
| epithelial tube formation | GO:0072175 | 130 | 0.018 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.018 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.018 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.018 | |
| ovulation cycle | GO:0042698 | 59 | 0.018 | |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.018 | |
| spindle assembly involved in female meiosis i | GO:0007057 | 2 | 0.018 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.018 | |
| protein localization to membrane | GO:0072657 | 108 | 0.018 | |
| regulation of cell activation | GO:0050865 | 289 | 0.018 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.018 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.018 | |
| response to inorganic substance | GO:0010035 | 96 | 0.018 | |
| negative regulation of binding | GO:0051100 | 39 | 0.018 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.018 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.018 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 15 | 0.018 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.018 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.018 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.018 | |
| response to growth factor | GO:0070848 | 198 | 0.018 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.017 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.017 | |
| neuron projection extension | GO:1990138 | 64 | 0.017 | |
| positive regulation of growth | GO:0045927 | 104 | 0.017 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.017 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.017 | |
| rna interference | GO:0016246 | 2 | 0.017 | |
| lipid modification | GO:0030258 | 65 | 0.017 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.017 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.017 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.017 | |
| protein localization to chromatin | GO:0071168 | 3 | 0.017 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.016 | |
| interleukin 6 production | GO:0032635 | 58 | 0.016 | |
| multicellular organism growth | GO:0035264 | 161 | 0.016 | |
| cellular response to starvation | GO:0009267 | 57 | 0.016 | |
| synaptic transmission | GO:0007268 | 329 | 0.016 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.016 | |
| ectodermal cell fate commitment | GO:0001712 | 1 | 0.016 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.016 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.016 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.016 | |
| positive regulation of semaphorin plexin signaling pathway | GO:2001262 | 1 | 0.016 | |
| myosin filament organization | GO:0031033 | 3 | 0.016 | |
| oocyte maturation | GO:0001556 | 18 | 0.016 | |
| nuclear envelope organization | GO:0006998 | 11 | 0.016 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.016 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.016 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.016 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.016 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.016 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.016 | |
| single fertilization | GO:0007338 | 82 | 0.016 | |
| cell growth | GO:0016049 | 130 | 0.016 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.016 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.016 | |
| neural tube formation | GO:0001841 | 108 | 0.016 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 34 | 0.016 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.016 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.016 | |
| regulation of cell size | GO:0008361 | 72 | 0.016 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.016 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.016 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.015 | |
| epithalamus development | GO:0021538 | 2 | 0.015 | |
| oxidation reduction process | GO:0055114 | 342 | 0.015 | |
| positive regulation of mitotic metaphase anaphase transition | GO:0045842 | 2 | 0.015 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.015 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.015 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.015 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.015 | |
| cardiac cell development | GO:0055006 | 41 | 0.015 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.015 | |
| cartilage development | GO:0051216 | 140 | 0.015 | |
| dna recombination | GO:0006310 | 92 | 0.015 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.015 | |
| gene silencing | GO:0016458 | 38 | 0.015 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.015 | |
| cerebellum development | GO:0021549 | 77 | 0.015 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.015 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.015 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.015 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.015 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.015 | |
| sensory system development | GO:0048880 | 3 | 0.015 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.014 | |
| cytokinesis | GO:0000910 | 17 | 0.014 | |
| gastrulation | GO:0007369 | 116 | 0.014 | |
| positive regulation of ubiquitin protein transferase activity | GO:0051443 | 4 | 0.014 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| cell cycle switching mitotic to meiotic cell cycle | GO:0051728 | 1 | 0.014 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.014 | |
| regulation of synapse maturation | GO:0090128 | 9 | 0.014 | |
| organic anion transport | GO:0015711 | 137 | 0.014 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.014 | |
| cerebellum formation | GO:0021588 | 1 | 0.014 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.014 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.014 | |
| fibrinolysis | GO:0042730 | 3 | 0.014 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.014 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 20 | 0.014 | |
| cell killing | GO:0001906 | 67 | 0.014 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.014 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.014 | |
| cerebral cortex development | GO:0021987 | 86 | 0.014 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.014 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.014 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.014 | |
| epithelial cell development | GO:0002064 | 159 | 0.014 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.014 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.014 | |
| regulation of organ growth | GO:0046620 | 61 | 0.014 | |
| myosin filament assembly | GO:0031034 | 2 | 0.014 | |
| astral microtubule organization | GO:0030953 | 3 | 0.014 | |
| chromosome condensation | GO:0030261 | 10 | 0.014 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.014 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.013 | |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 7 | 0.013 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.013 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.013 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.013 | |
| neural tube closure | GO:0001843 | 90 | 0.013 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.013 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.013 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.013 | |
| t cell proliferation | GO:0042098 | 120 | 0.013 | |
| chromosome separation | GO:0051304 | 14 | 0.013 | |
| muscle system process | GO:0003012 | 141 | 0.013 | |
